Literature DB >> 16076422

Relationships among psychosocial functioning, diagnostic comorbidity, and the recurrence of generalized anxiety disorder, panic disorder, and major depression.

Benjamin F Rodriguez1, Steven E Bruce, Maria E Pagano, Martin B Keller.   

Abstract

The present study examined the relationships among impaired psychosocial functioning, comorbidity, and the cumulative probability of future recurrence of anxiety disorders and major depression in recovered patients. Participants were part of the Harvard/Brown Anxiety Disorders Research Program (HARP), a naturalistic, prospective, longitudinal study of anxiety disorders in psychiatric outpatients. Using proportional hazards regressions, worsening psychosocial impairment in general and in specific areas was significantly associated with an increased risk of panic disorder, generalized anxiety disorder, and major depression recurring, even after controlling for diagnostic comorbidity. These results are consistent with and extend similar findings for patients with major depression [Leon, A., Solomon, D. A., Mueller, T. I., Endicott, J., Posternak, M., Judd, L. L., et al. (1999). The range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment. Psychological Medicine, 29, 869-878; Leon, A., Solomon, D. A., Mueller, T. I., Endicott, J., Posternak, M., Judd, L. L., et al. (2000). A brief assessment of psychosocial functioning of subjects with bipolar I disorder: The LIFE-RIFT. The Journal of Nervous and Mental Disease, 188, 805-812], and suggest that increased psychosocial impairment may be a risk factor for relapse.

Entities:  

Mesh:

Year:  2004        PMID: 16076422     DOI: 10.1016/j.janxdis.2004.10.002

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  22 in total

1.  An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses.

Authors:  A Carlo Altamura; Marta Serati; Alessandra Albano; Riccardo A Paoli; Ira D Glick; Bernardo Dell'Osso
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-02-18       Impact factor: 5.270

2.  Predictors of anxiety recurrence in the Coordinated Anxiety Learning and Management (CALM) trial.

Authors:  Jerome H Taylor; Ewgeni Jakubovski; Michael H Bloch
Journal:  J Psychiatr Res       Date:  2015-04-04       Impact factor: 4.791

3.  Health-related quality of life across the anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions (NESARC).

Authors:  Jonathan S Comer; Carlos Blanco; Deborah S Hasin; Shang-Min Liu; Bridget F Grant; J Blake Turner; Mark Olfson
Journal:  J Clin Psychiatry       Date:  2010-08-24       Impact factor: 4.384

4.  Anxiety disorders and intimate relationships: a study of daily processes in couples.

Authors:  Talia I Zaider; Richard G Heimberg; Masumi Iida
Journal:  J Abnorm Psychol       Date:  2010-02

Review 5.  Role of atypical antipsychotics in the treatment of generalized anxiety disorder.

Authors:  Rachel Hershenberg; Daniel F Gros; Olga Brawman-Mintzer
Journal:  CNS Drugs       Date:  2014-06       Impact factor: 5.749

6.  The DSM-IV definition of severity of major depression: inter-relationship and validity.

Authors:  V Lux; S H Aggen; K S Kendler
Journal:  Psychol Med       Date:  2010-01-08       Impact factor: 7.723

7.  Risk factors for anxiety disorders: common and specific effects in a national sample.

Authors:  Carlos Blanco; José Rubio; Melanie Wall; Shuai Wang; Chelsea J Jiu; Kenneth S Kendler
Journal:  Depress Anxiety       Date:  2014-02-27       Impact factor: 6.505

Review 8.  Psychiatric epidemiology: challenges and opportunities.

Authors:  Ronald C Kessler
Journal:  Int Rev Psychiatry       Date:  2007-10

9.  Deterioration in psychosocial functioning predicts relapse/recurrence after cognitive therapy for depression.

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Robin B Jarrett
Journal:  J Affect Disord       Date:  2008-06-09       Impact factor: 4.839

Review 10.  Comorbid anxiety in bipolar disorder alters treatment and prognosis.

Authors:  Rif S El-Mallakh; Michael Hollifield
Journal:  Psychiatr Q       Date:  2008-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.